Post-kala-azar Dermal Leishmaniasis: Clinical Trials

2 trials for Post-kala-azar Dermal Leishmaniasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow Post-kala-azar Dermal Leishmaniasis: new trials by email Literature Review of Post-kala-azar Dermal Leishmaniasis trials Research Report on Post-kala-azar Dermal Leishmaniasis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Effectiveness of Short-course AmBisome in the Treatment of PKDL in Bangladesh
AmBisome - Post-kala-azar Dermal Leishmaniasis
Phase 4CompletedMedecins Sans Frontieres, Netherlands2802014-04-082017-10-17
A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL)
Mitefosine - Post-kala-azar Dermal Leishmaniasis
Phase 4CompletedInternational Centre for Diarrhoeal Disease Research, Bangladesh362013-01-012014-11-05

Narrower conditions

Leishmaniasis (1)  ·  Leishmaniasis, Visceral (1)

Broader conditions

Euglenozoa Infections (2)  ·  Infections (2)  ·  Parasitic Diseases (2)  ·  Protozoan Infections (2)  ·  Vector Borne Diseases (2)  ·  Leishmaniasis (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Infectious (1)  ·  Skin Diseases, Parasitic (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

liposomal amphotericin B (1)

Sponsors

International Centre for Diarrhoeal Disease Research, Bangladesh (1)  ·  Medecins Sans Frontieres, Netherlands (1)

Countries

Bangladesh (1)

Top investigators

Dinesh Mondal, MB; MD; PhD (1)  ·  Koert Ritmeijer, PhD (1)